⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Ultragenyx Pharmaceutical Inc.(RARE) Shareholders
prnewswire.com
RARE
Holzer & Holzer, LLC Reminds RARE Investors of the April 6, 2026 Lead Plaintiff Deadline in the Ultragenyx Pharmaceutical Inc. Securities Class Action
globenewswire.com
RARE
RARE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
RARE
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
accessnewswire.com
RARE
Pomerantz LLP Highlights Class Action Filing Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
Ultragenyx to Participate at Investor Conferences in March
globenewswire.com
RARE
ROSEN, A RANKED AND LEADING FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
globenewswire.com
RARE
LEVI & KORSINSKY, LLP: PHASE III CLINICAL TRIAL DESIGN AND ENDPOINT SELECTION AT CENTER OF ULTRAGENYX PHARMACEUTICAL SECURITIES LITIGATION
globenewswire.com
RARE
Ultragenyx Pharmaceutical Inc. Securities Class Action Filed; Lead Plaintiff Deadline April 6, 2026 – RGRD Law
globenewswire.com
RARE
Form 8-K
sec.gov
RARE